Study of the Efficacy of Raberprazole Combined with Levofloxacin and Furazolidon in the Treatment of Helicobacter Intection
Guanghua Tang
Abstract
Guanghua Tang
Abstract
Objective:The aim of this study was to test the efficacy of Raberprazole combines Levofloxacin and Furazolidone for the treatment for Helicobacter pylori infection.Methods: Eighty-six H.pylori-positive patients(contain chronic gastritic and peptic ulcer) were randomized divided into therapy group and control group: Rabeprazole 10 mg bid +Levofloxacin 0.2g bid(therapy group)/ Amoxicillin 1.0g bid(control group)+Furazolidone 0.1g bid(therapy group)/Metronidizone 0.4g bid(control group) for 1 week.H.pylori was retested four weeks later.Results: The eradication rates of two regimen were: therapy group was 84.8%;control group was 75.0%.The eradication rates of H.pylori of the two groups were significant different(P0.05).Conclusions: Raberprazole+levofloxacin+furazolidone triple therapy for H.Pylori infection is effective、cheap and smaller side effect,it is worthy to be extended as one of the threatments for Helicobacter pylori infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:The aim of this study was to test the efficacy of Raberprazole combines Levofloxacin and Furazolidone for the treatment for Helicobacter pylori infection.Methods: Eighty-six H.pylori-positive patients(contain chronic gastritic and peptic ulcer) were randomized divided into therapy group and control group: Rabeprazole 10 mg bid +Levofloxacin 0.2g bid(therapy group)/ Amoxicillin 1.0g bid(control group)+Furazolidone 0.1g bid(therapy group)/Metronidizone 0.4g bid(control group) for 1 week.H.pylori was retested four weeks later.Results: The eradication rates of two regimen were: therapy group was 84.8%;control group was 75.0%.The eradication rates of H.pylori of the two groups were significant different(P0.05).Conclusions: Raberprazole+levofloxacin+furazolidone triple therapy for H.Pylori infection is effective、cheap and smaller side effect,it is worthy to be extended as one of the threatments for Helicobacter pylori infection.
Key concepts: Furazolidone, Levofloxacin, Rabeprazole, Medicine, Helicobacter pylori, Amoxicillin, Gastroenterology, Internal medicine